Educational content on VJNeurology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ESOC 2026 | Characterization of intracerebral hemorrhage with mixed location hemorrhages

João Pinho, MD, RWTH Aachen University, Aachen, Germany, discusses the findings of a single-center retrospective observational study exploring the characterization of intracerebral hemorrhage with mixed location hemorrhages. Dr Pinho highlights findings showing that amyloid pathology is not the predominant cause of hemorrhage in these patients. This interview took place at the 12th European Stroke Organisation Conference (ESOC) in Maastricht, The Netherlands.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

Transcript

So our study was a single-center retrospective observational study in which we examined all patients, all consecutive patients with intracerebral hemorrhage and we classified them in three groups. The patients with mixed location hemorrhage, patients with cerebral amyloid angiopathy, and patients with arteriosclerotic small vessel disease. And we characterized these three groups of patients according to the demographic characteristics, clinical characteristics, and imaging characteristics...

So our study was a single-center retrospective observational study in which we examined all patients, all consecutive patients with intracerebral hemorrhage and we classified them in three groups. The patients with mixed location hemorrhage, patients with cerebral amyloid angiopathy, and patients with arteriosclerotic small vessel disease. And we characterized these three groups of patients according to the demographic characteristics, clinical characteristics, and imaging characteristics. And what we saw was that some of the characteristics of mixed location hemorrhage patients indeed overlap with arteriosclerotic small vessel disease, not so much with cerebral amyloid angiopathy. And one of the things that we also examined in our study were the CSF markers for neurodegeneration when we compared patients with mixed location hemorrhage and CAA patients, cerebral amyloid angiopathy patients, and we could see that only about a third of patients with mixed hemorrhage locations had evidence in CSF of amyloid pathology. We also found that ICH, intracerebral hemorrhage recurrence risk was intermediate between patients with cerebral amyloid angiopathy and patients with arteriosclerotic small vessel disease. So, in conclusion, our study supports this notion that patients with ICH, with mixed location hemorrhage, do not have amyloid pathology as the predominant pathology as a cause for hemorrhage.

This transcript is AI-generated. While we strive for accuracy, please verify this copy with the video.

Read more...